Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 81

Results For "CRO"

5783 News Found

NunaBio secures £6.5 million to scale DNA manufacturing platform
Biotech | May 19, 2026

NunaBio secures £6.5 million to scale DNA manufacturing platform

Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics


Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children
Hospitals | May 19, 2026

Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children

Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin
Healthcare | May 19, 2026

HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin

Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development


Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer
Clinical Trials | May 19, 2026

SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer

The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients


Alivus Life Sciences posts steady FY26 growth as margins surge past guidance
News | May 19, 2026

Alivus Life Sciences posts steady FY26 growth as margins surge past guidance

The company reported free cash flow of Rs. 2,590 Mn for FY26


Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial
Clinical Trials | May 19, 2026

Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial

Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm